Moolec Science Statistics
Total Valuation
Moolec Science has a market cap or net worth of $24.38 million. The enterprise value is $44.54 million.
Important Dates
The next estimated earnings date is Thursday, May 29, 2025, before market open.
| Earnings Date | May 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Moolec Science has 40.00 million shares outstanding. The number of shares has increased by 1.44% in one year.
| Current Share Class | 40.00M |
| Shares Outstanding | 40.00M |
| Shares Change (YoY) | +1.44% |
| Shares Change (QoQ) | +0.72% |
| Owned by Insiders (%) | 38.16% |
| Owned by Institutions (%) | 0.18% |
| Float | 8.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.99 |
| Forward PS | 5.95 |
| PB Ratio | 8.72 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 7.90.
| Current Ratio | 1.48 |
| Quick Ratio | 0.72 |
| Debt / Equity | 7.90 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.19 |
Financial Efficiency
Return on equity (ROE) is -174.68% and return on invested capital (ROIC) is -28.64%.
| Return on Equity (ROE) | -174.68% |
| Return on Assets (ROA) | -21.69% |
| Return on Invested Capital (ROIC) | -28.64% |
| Return on Capital Employed (ROCE) | -36.68% |
| Revenue Per Employee | $150,633 |
| Profits Per Employee | -$159,241 |
| Employee Count | 52 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 3.17 |
Taxes
| Income Tax | -342,804 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.22% in the last 52 weeks. The beta is -0.34, so Moolec Science's price volatility has been lower than the market average.
| Beta (5Y) | -0.34 |
| 52-Week Price Change | -58.22% |
| 50-Day Moving Average | 0.70 |
| 200-Day Moving Average | 0.83 |
| Relative Strength Index (RSI) | 43.42 |
| Average Volume (20 Days) | 146,333 |
Short Selling Information
The latest short interest is 101,030, so 0.25% of the outstanding shares have been sold short.
| Short Interest | 101,030 |
| Short Previous Month | 102,842 |
| Short % of Shares Out | 0.25% |
| Short % of Float | 1.14% |
| Short Ratio (days to cover) | 5.06 |
Income Statement
In the last 12 months, Moolec Science had revenue of $7.83 million and -$8.28 million in losses. Loss per share was -$0.22.
| Revenue | 7.83M |
| Gross Profit | -639,496 |
| Operating Income | -9.14M |
| Pretax Income | -8.08M |
| Net Income | -8.28M |
| EBITDA | -8.07M |
| EBIT | -9.14M |
| Loss Per Share | -$0.22 |
Full Income StatementBalance Sheet
The company has $1.93 million in cash and $22.09 million in debt, giving a net cash position of -$20.16 million or -$0.50 per share.
| Cash & Cash Equivalents | 1.93M |
| Total Debt | 22.09M |
| Net Cash | -20.16M |
| Net Cash Per Share | -$0.50 |
| Equity (Book Value) | 2.80M |
| Book Value Per Share | 0.07 |
| Working Capital | 3.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.70 million and capital expenditures -$402,063, giving a free cash flow of -$6.10 million.
| Operating Cash Flow | -5.70M |
| Capital Expenditures | -402,063 |
| Free Cash Flow | -6.10M |
| FCF Per Share | -$0.15 |
Full Cash Flow StatementMargins
Gross margin is -8.16%, with operating and profit margins of -116.72% and -105.71%.
| Gross Margin | -8.16% |
| Operating Margin | -116.72% |
| Pretax Margin | -110.09% |
| Profit Margin | -105.71% |
| EBITDA Margin | -103.07% |
| EBIT Margin | -116.72% |
| FCF Margin | n/a |